Studying the Effects of Phentermine on Eating Behavior
Completed · Phase 4 · Has a placebo group
Conditions studied: Obesity
In brief
The goal of this study is to determine whether one week of phentermine compared to placebo administration results in changes in food intake during a laboratory meal.
Key facts
- Study ID
- NCT01886937
- Run by
- New York State Psychiatric Institute
- People needed
- 13
- Starts
- 2012-07-01
- Expected to finish
- 2014-06-01
- Last updated by the study team
- 2017-07-31
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- BMI between 30-40kg/m2
- Stable weight (+5 lbs) for a minimum of 3 months
- Systolic Blood Pressure <140mm Hg
- Diastolic Blood Pressure <90 mm Hg
- Pulse <95 beats per minute
- English language proficiency
You may not qualify if…
- Previous unsuccessful trial of phentermine
- Prior adverse reaction to phentermine
- On any antidepressant medications,especially monoamine oxidase inhibitors(MAOI)
- History of neurological disorder (e.g. dementia)
- History of moderate or severe head injury
- Current or past history of coronary artery disease
- Current or past history of stroke or transient ischemic attack
- Current or past history of heart arrhythmias
- Current of past history of congestive heart failure
- Current or past history of peripheral artery disease
- Current or past history of liver disease
- Current or past history of kidney disease
- Uncontrolled diabetes mellitus (type I or II)
- Narrow-angle glaucoma
- Hypo- or hyper-thyroidism not adequately treated
- On medications (prescribed or OTC) known to affect appetite (e.g. diet pills), weight, or metabolism
- Current or past history (within the past 12 months) of major depression
- Current or past history (past 12 months) of alcohol or drug abuse or dependence
- Current or past history (lifetime) of amphetamine abuse or dependence
- Known history of learning disorder or developmental disability
- Current or past Attention Deficit Hyperactivity Disorder (ADHD)
- Pregnancy, planning to become pregnant, or lactation within the previous 6 months
- Waist circumference greater than 188cm
- Indwelling metallic object (e.g., pacemaker,pump), non-removable metal jewelry, medicinal patch or recent metallic ink tattoo
- Significant claustrophobia
Where it is running
- The New York State Psychiatric Institute at Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.